Changes in the expression of Toll-like receptors, cytokines and chemokines in the cells of the mucous membrane of the oropharynx in children with COVID-19

Abstract

Introduction. COVID-19 is a severe respiratory disease caused by the β-coronavirus SARS-CoV-2, which is characterized by immune-mediated tissue and organ damage. It has been proven that the disease in children is relatively easy compared to adults, and the mechanisms of innate immunity play an important role in this.

The aim of the investigation was to study the expression of genes encoding the innate immunity receptors TLR4, TLR7, as well as to analyze changes in the expression of proinflammatory cytokines - interleukin(IL)-1β, tumor necrosis factor (TNF)-α and interferon (IFN)-α - in children with COVID-19, depending on the severity of the disease.

Material and methods. The study included 55 children with a confirmed diagnosis of COVID-19. Patient groups were formed on the basis of complaints and clinical manifestations. The 1st group of asymptomatic children included 9 people. The 2nd group included children were with a mild form of the course - 36 people, the 3rd group consisted of children with a moderate form of the course (10 people). The group of comparison consisted of 25 healthy children. RNA was isolated from the obtained material and the level of gene expression was determined by polymerase chain reaction in real time, and the level of cytokines in the supernatant was determined by the method of multiplex immunofluorescence analysis.

Results. A statistically significant increase in the expression of genes for innate immunity receptors (TLR4, TLR7) in the cells of the mucous membrane of the oropharynx in children with COVID-19 has been shown. The expression of TLR4 and TLR7 was, respectively, 2.6 and 7.2 times higher in children with moderate course compared with the healthy group. At the same time, an increase in the level of expression of pro-inflammatory cytokines (IL-1β, TNFα, IFN-α) at the gene and protein levels, associated with the severity of COVID-19 was revealed. Our study also showed an increase in the production of chemokines, which correlated with the severity of the disease.

Discussion. An increase in the expression level of the TLR4 and TLR7 genes by oropharyngeal mucosa cells in children with COVID-19 indicates their role in the pathogenesis of the disease. The main function of TLR4 and TLR7 is to recognize pathogen-associated molecular patterns, namely, the spike glycoprotein involved in the penetration of the virus into target cells and the single-stranded RNA of the virus. Activation of TLR4 and TLR7 leads to Toll-induced expression of genes for proinflammatory cytokines (IL-1β, TNFα, IFN-α) and chemokines, a significant increase in gene expression and protein production of which we have demonstrated. This plays a huge role in the development of the inflammatory response and indicates changes in the innate immunity of the mucous membranes in COVID-19.

Conclusion. The data obtained by us can be used for further study and determination of molecular genetic markers associated with COVID-19 in children, which will allow us to select the optimal therapy option in the future.

Keywords:innate immunity; COVID-19; Toll-like receptors; proinflammatory cytokines; chemokines

For citation: Gankovskaya L.V., Zinina E.V, Gankovskii V.A., Semushkin A.R. Changes in the expression of Toll-like receptors, cytokines and chemokines in the cells of the mucous membrane of the oropharynx in children with COVID-19. Immunologiya. 2021; 42 (3): 222-31. DOI: https://doi.org/10.33029/0206-4952-2021-42-3-222-231 (in Russian)

Funding. The study had no sponsor support.

Conflict of interests. The authors declare no conflict of interests.

References

1. Gudima G.O., Khaitov R.M., Kudlay D.A., Khaitov M.R. Molecular immunological aspects of diagnostics, prevention and treatment of coronavirus infection. Immunologiya. 2021; 42 (3): 198-210. DOI: https://doi.org/10.33029/0206-4952-2021-42-3-198-210 (in Russian)

2. Brooke G.N., Prischi F. Structural and functional modelling of SARS-CoV-2 entry in animal models. Sci Rep. 2020; 10 (1): 15-7. DOI: 10.1038/s41598-020-72528-z

3. Kovalchuk L.V., Gankovskaya L.V., Meshkova R.Ya. Clinical immunology and allergology with the basics of general immunology: textbook. Moscow: GEOTAR-Media, 2011. 640 p. (in Russian)

4. Zhao Y., Kuang M., Li J., Zhu L., Jia Z., Guo X., Hu Y., Kong J., Yin H., Wang X. SARS-CoV-2 spike protein interacts with activates TLR4. Cell Research. 2021. DOI: 10.1038/s41422-021-00495-9

5. Aboudounya M.M., Heads R.J. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation. Mediators of Inflammation. 2021; 2021 (12): 1-18. DOI: 10.1155/2021/8874339

6. Gankovskaya L.V., Bykova V.P., Namasova-Baranova L.S., Karaulov A.V., Rahmanova I.V., Gankovskii V.A., Merkushova C.D., Svitich O.A. Innate immunity gene expression by epithelial cells of upper respiratory tract in children with adenoid hypertrophy. Auris Nasus Larynx. 2018; 45 (4): 753-9. DOI: 10.1016/j.anl.2017.11.011

7. Khanmohammadi S., Rezaei N. Role of Toll-like receptors in the pathogenesis of COVID-19. J Med Virol. 2021; 93 (5): 2735-9. DOI: 10.1002/jmv.26826

8. Yasuhara J., Kuno T., Takagi H., Sumitomo N. Clinical characteristics of COVID-19 in children: A systematic review. Pediatric Pulmonology. 2020; 55 (10): 2565-75. DOI: 10.1002/ppul.24991

9. Strambovskaya N.N., Dutova A.A., Dagbaeva S.D. Taking, storage, transportation of clinical material for PCR diagnostics: guidelines. RIC GBOU VPO ChGMA, 2013. 21 p. (in Russian)

10. Merkushova E.D., Khasanova E.M., Gankovskaya L.V. Huperexpression of NLRP1 inflammasome complex genes and cytokines IL-1P, IL-18 in biopthates of lesion and healthy skin of patients with psoriasis. Immunologiya. 2021; 42 (1): 21-8. DOI: 10.33029/0206-4952-2021-42-1-21-28 (in Russian)

11. Rebrikov D.V. PCR «In Real Time». Moscow: BINOM. Knowledge Laboratory, 2009. 223 p. ISBM: 978-5-00101-085-2 (in Russian)

12. Bio-Rad: Bio-Plex Pro Human Cytokine Assays. Instruction Manual. 23 c.

13. Brandao S.C.S., Ramos J.O.X., Dompieri L.T., Godoi E.T.A.M., Figueiredo J.L., Sarinho E.S.C., Chelvanambi S., Aikawa M. Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities? Cytokine & Growth Factor Reviews. 2020; 58: 102-10. DOI: 10.1016/j.cytogfr. 2020.09.002

14. BanerjeeA.K., Blanco M.R., Bruce E.A,Honson D.D, Chen L.M., Chow A., Bhat P., Ollikainen M., Quinodoz S.A., Loney C., Thai J., Miller Z.D., Lin A.E., Schmidt M.M., Stewart D.G., Goldfab D., Lorenzo G., Rihn S.J. Guttman M. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses. Cell. 2020; 183 (5): 1325 -39. DOI: 10.1016/j.cell.2020.10.004

15. Gu Q., Shi Q., Yang H. The Role of TLR and Chemokine in Wear Particle-Induced Aseptic Loosening. Journal of Biomedicine and Biotechnology. 2012; 1-9. DOI: 10.1155/2012/596870

16. Paschenkov M.V., Khaitov M.R. Immune response against epidemic coronaviruses. Immunologiya. 2020; 41 (1): 5-18. DOI: 10.33029/0206-4952-2020-41-1-5-18 (in Russian)

17. Buonsenso D., Sali M., Pata D., De Rose C., Sanguinetti M., Valentini P., Delogu G. Children and COVID-19: Microbiological and immunological insights. Pediatric Pulmonology. 2020; 55 (10): 254755. DOI: 10.1002/ppul.24978

18. Fialkowski A., Gernez Y., Arya P., Weinacht K., Kinane T.B., Yonker L. Insight into the pediatric and adult dichotomy of CO-VID-19: Age-related differences in the immune response to SARS-CoV-2 infection. Pediatric Pulmonology. 2020; 55 (10): 2556-64. DOI: 10.1002/ppul.24981

19. Cuevas A.M., Clark J.M., Potter J.J. Increased TLR/MyD88 signaling in patients with obesity: is there a link to COVID-19 disease severity? Int. J. Obes. 2021; 26: 1-3. DOI: 10.1038/s41366-021-00768-8

20. Sherwani S., Khan M.W.A. Cytokine Response in SARS-CoV-2 Infection in the Elderly. Journal of Inflammation Research. 2020; 13: 737-747. DOI: 10.2147/JIR.S276091

21. Boldyreva M.N. SARS-CoV-2 virus and other epidemic coronaviruses: pathogenetic and genetic factors for the development of infections. Immunologiya. 2020; 41 (3): 197-205. DOI: 10.33029/0206-4952-2020-41-3-197-205 (in Russian)

22. SchaeferT.M., DesouzaK., Fahey J.V., Beagley K.W.,Wira C.R.. Toll-like receptor (TLR) expression and TLR-mediated cytokine/chemokine production by human uterine epithelial cells. Immunology. 2004; 112 (3): 428-36. DOI: 10.1111/j.1365-2567.2004. 01898.x

23. Khalil B.A., Elemam N.M., Maghazachi A.A. Chemokines and chemokine receptors during COVID-19 infection. Computational and Structural Biotechnology Journal. 2021; 19: 976-988. DOI: 10.1016/j.csbj.2021.01.034

24. Lai K.N., Leung J.C.K., Metz C.N., Lai F.M., Bucala R., Lan H.Y. Role for macrophage migration inhibitory factor in acute respiratory distress syndrome. J. Pathol. 2003; 199 (4): 496-508. DOI: 10.1002/path.1291

25. Ackermann M., Mentzer S.J., Kolb M., Jonigk D. Inflammation and intussusceptive angiogenesis in COVID-19 everything in and out of flow. European Respiratory journal. 2020; 56 (5). DOI: 10.1183/13993003.03147-2020

26. Wong L.S.Y., Loo E.X.L., Kang A.Y.H., Lau H.X., Tam-byah P.A., Tham E.H. Age-Related Differences in Immunological Responses to SARS-CoV-2. The Journal of Allergy and Clinical Immunology: In Practice. 2020; 8 (10): 3251-8. DOI: 10.1016/j.jaip.2020.08.026

27. Li L., Li J., Gao M., Fan H., Wang Y., Xu X., Chen C., Liu J., Kim J., Aliyari R., Zhang J., Jin Y., Li X., Ma F., Shi M., Cheng G., Yang H. Interleukin-8 as a Biomarker for Disease Prognosis of Coro-navirus Disease-2019 Patients. Frontiers in Immunology. 2021; 11: 602395. DOI: 10.3389/fimmu.2020.602395

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)


JOURNALS of «GEOTAR-Media»